Skip to main content

Table 7 Free fatty acid profile of HBV cirrhosis patients in comparison of controls

From: Serum lipid profile as a marker of liver impairment in hepatitis B Cirrhosis patients

Fatty Acids (g/100 g)

Controls

Patients

C-14:0

1.29 ± 0.7

1.34 ± 0.9

C-16 : 0

19.84 ± 3.2

24.63 ± 5.1*

C-18 : 0

14.30 ± 5.6

17.80 ± 6.9

C-20 : 0

0.82 ± 0.5

0.16 ± 0.3*

C-24 : 0

0.11 ± 0.1

0.009 ± 0.03

C-14 : 1

0.14 ± 0.2

0.45 ± 0.4*

C-16 : 1

2.25 ± 0.8

3.58 ± 1.1*

C-18 : 1

22.50 ± 5.1

24.36 ± 3.1

C-22 : 1

1.70 ± 0.8

0.88 ± 0.6*

C-24 : 1

ND

ND

C-18 : 2

27.99 ± 3.9

20.48 ± 3.8*

C-18 : 3

0.29 ± 0.1

0.07 ± 0.1

C-20 : 3

0.61 ± 0.4

0.18 ± 0.3

C-20 : 4

5.40 ± 2.4

2.55 ± 1.2*

C-20 : 5

0.54 ± 0.1

ND*

C-22 : 5

0.05 ± 0.1

0.12 ± 0.1

C-22 : 6

0.09 ± 0.2

0.33 ± 0.4*

  1. Values are mean ± standard deviation,* shows significant difference from HBV-cirrhosis patients with comparison of healthy controls a p < 0.05 (t-test). myristic acid (C14:0), myristoleic acid (C14:1), palmitic acid (C16:0), palmitoleic acid (C16:1), stearic acid (C18:0), oleic acid (C18:1), linoleic acid (C18:2), α-linolenic acid (C18:3), arachidic acid (C20:0), eicosatrienoic acid (C-20:3), arachidonic acid (C20:4), eicosapentaenoic acid (EPA (C20:5), docosenoic acid (C22:1), docosahexaenoic acid (DHA (C22:6), nervonic acid(C24:1), not detected (ND)